Monday, December 23, 2024
HomeTagsArix Bioscience

Arix Bioscience

Sorriso Pharmaceuticals Launches with $31 Million to Develop Novel Class of Orally Delivered Cytokine Antibodies to Treat Inflammatory Conditions

Sorriso Pharmaceuticals, a company focused on transforming anti-inflammatory antibody therapy, announced the company has closed on a $31 million Series A financing. The round...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics